Early access to dissolvable antibiotic beads for bone infections
Part of Skin clinical trials.
This program offers early access to STIMULAN VG, a dissolvable bead that releases antibiotics directly into an infected bone area, when no other treatment options are available. It may help people with serious bone infections that haven't responded to standard care.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must have a serious or life-threatening condition that current treatments have not helped.
- You must not be able to get the treatment through a regular clinical trial.
- Your doctor must ask the company for permission to use this treatment for you.
- You must agree to be closely monitored during and after treatment.
- You must provide written informed consent before starting.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a special antibiotic bone filler (STIMULAN VG) compared to standard care for people with a serious pressure ulcer that has infected the bone. You need to be able to have surgery to clean and close the wound.
This study tests whether placing antibiotic-coated beads directly into the infected area helps treat bone or joint infections in the lower leg, foot, or ankle. The beads release antibiotics slowly to fight the infection at the source.
This trial tests whether putting antibiotics directly inside the bone during surgery can improve outcomes for an infected knee prosthesis when the implant is being kept. It may help more people avoid needing full implant removal and replacement.
This trial tests a dissolvable antibiotic implant placed during surgery to treat long-standing bone infections (osteomyelitis) that haven't healed with antibiotics alone. It may help people who need surgery to remove infected bone.
This trial tests a special glass material (bioactive glass S53P4) placed into the bone after surgery to treat a diabetic foot infection in the forefoot. It may help heal the infection better than standard care.
This study tests whether adding a bone-strengthening drug (bisphosphonate) to standard antibiotics (vancomycin) helps clear chronic bone infections (osteomyelitis) caused by Staph or MRSA, after surgery. It may help improve healing and prevent the infection from coming back.
Hear when a new Stage IV Pressure Ulcer trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.